BFS – The Gold Standard for Ophthalmic Unit Dose and Vial Solutions A Trusted CDMO for Ophthalmic Products Unither Pharmaceuticals is a global Contract Development and Manufacturing Organization (CDMO) specializing in sterile unit-dose, vial, and eye drop solutions. As a trusted pharmaceutical subcontractor, we support start-ups, laboratories, and large pharmaceutical companies from early-stage development to full-scale commercial manufacturing. With manufacturing sites in the United States (Rochester, NY), France, and Brazil, we provide a complete ophthalmic portfolio, including preservative-free unit-dose and multidose vials. State-of-the-Art Ophthalmic Manufacturing in the United States Unither Manufacturing LLC – Rochester, NY Our Rochester facility is a center of excellence for unit-dose, vial, and preservative-free ophthalmic formulations. Following a $106 million investment in 2024, the site now features: A 43,000 sq. ft. expansion to meet growing market demand. Advanced BFS production lines for sterile eye drops and multidose vials. Cutting-edge R&D capabilities for ophthalmic drug development. Coutances, France – FDA-Certified BFS Eye Drops and Multidose Vial Technology Our FDA-certified Coutances site in France specializes in the production of preservative-free multidose (PFMD) ophthalmic vials and BFS technology for sterile unit-dose eye drops. These solutions offer an alternative to traditional unit-dose formats while maintaining sterility over multiple uses. Why BFS is the Best Choice for Ophthalmic Eye Drops & Vials Blow-Fill-Seal (BFS) technology is recognized as the gold standard for ophthalmic drug delivery, offering: Preservative-Free Formulations – Reduces irritation and enhances patient safety. High Sterility Assurance – A fully automated, aseptic process prevents contamination. Unit-Dose and Vial Flexibility – Solutions for diverse patient and market needs. Comprehensive CDMO Services for Ophthalmic Drug Development Unither Pharmaceuticals provides end-to-end ophthalmic manufacturing solutions, including: Formulation Development – Expertise in sterile eye drops, suspensions, and multidose vials. BFS Manufacturing – High-volume production for unit-dose, multidose, and preservative-free vial solutions. Regulatory Compliance – FDA, EMA, Health Canada, and global certifications. Custom Packaging – Tailored unit-dose and vial solutions for optimal patient compliance. Patient-Centered Approach: Aligning with Industry Best Practices At Unither Pharmaceuticals, we are committed to ensuring that our ophthalmic products align with the highest standards of patient care. As highlighted by the American Academy of Ophthalmology (AAO), patient-centered care is a key priority for the industry. “Measuring patient-centered outcomes reflects our attempts to measure what we’re already doing.” – Dr. Anne Coleman, President-Elect, AAO. This perspective reinforces our mission to develop and manufacture ophthalmic unit-dose, vial, and eye drop solutions that not only meet regulatory and industry standards but also prioritize patient safety, convenience, and therapeutic effectiveness. Partner with a CDMO That Scales with Your Growth From early-stage ophthalmic drug development to full-scale commercial manufacturing, Unither Pharmaceuticals is the subcontractor of choice for start-ups, biotech innovators, and global pharma leaders. Contact Us Unither Manufacturing LLC 755 Jefferson Road, Rochester, NY 14623 Phone: +1 585-475-9000 Email: contact@unither-pharma.com
